Business
Notice of Interim Results
Notice of Interim Results.
About this update from Cambridge Cognition Holdings Plc
[{"type":"text","content":"\n\nCambridge Cognition Holdings Plc\n \n(\"Cambridge Cognition\" or the \"Company\")\n \nNotice of Interim Results\n \nCambridge Cognition Holdings plc (AIM: COG), which develops and markets digital solutions to assess brain health, will announce its unaudited interim results for the six months ended 30 June 2023 on Tuesday 26 September 2023.\n \nEnquiries\n \n\n\n\n\nCambridge Cognition Holdings Plc \nMatthew Stork, Chief Executive Officer \nStephen Symonds, Chief Financial Officer \n \n\n\nTel: 012 2381 0700 \[email protected] \n\n\n\n\nPanmure Gordon (UK) Limited (NOMAD and Joint Broker) \nFreddy Crossley / Emma Earl / Mark Rodgers\nRupert Dearden \n \n\n\nTel: 020 7886 2500 \n(Corporate Finance) \n(Corporate Broking) \n\n\n\n\nDowgate Capital Limited (Joint Broker) \nDavid Poutney / James Serjeant \n \n\n\nTel: 020 3903 7715 \n \n\n\n\n\nIFC Advisory Ltd (Financial PR and IR) \nTim Metcalfe / Graham Herring / Zach Cohen \n\n\nTel: 020 3934 6630 \n [email protected]\n\n\n\n\n \nAbout Cambridge Cognition\n \nCambridge Cognition is a technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The Company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in pharmaceutical and healthcare industries.\nFor further information visit www.cambridgecognition.com\n\n","length":4658,"tagName":"div"}]